Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

GSK and Amicus Therapeutics Revise Migalastat Agreement

November 26, 2013

GSK and Amicus Therapeutics revise Fabry agreement entered into in July 2012.

Catalent, Pure MHC Partner

November 26, 2013

Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.

Catalent Opens Clinical Trial Supply Facility

November 26, 2013

Catalent opens clinical-trial supply facility in Shanghai, China.

Coldstream Laboratories Names Head of Formulation Development

November 26, 2013

Coldstream Laboratories names director of formulation development.

Catalent Signs RL21 Anti-Cancer Development Deal with Pure MHC

November 22, 2013

Catalent has signed a product development agreement with immunology company Pure MHC (major histocompatibility complex), which specializes in MHC-based diagnostics and therapeutics.

USP Seeks Experts for 2015-2020 Council of Experts

November 15, 2013

USP issues call for candidates for its 2015-2020 Council of Experts.

Collaboration Uses Next-Gen Sequencing for Biosafety Assessments

November 15, 2013

Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing based biosafety assessments to detect and identify viral contaminants within biologic compounds.

DCAT Names Officers

November 11, 2013

Lyra Myers, associate director and value creation agent at Roche, has been elected DCAT president.

Pfenex Awarded Subcontract by Leidos to Develop Malaria Antigen

November 4, 2013

Pfenex receives subcontract from Leidos to develop a production process for the malaria antigen Plasmodium falciparum reticulocyte-binding homolog 5 (Rh5).

ADVERTISEMENT

ADVERTISEMENT

Click here